Study About the Evolution of Severe Late Onset Pompe Disease Patient With Pulmonary Dysfunction and Receiving Myozyme®
CompletedOBSERVATIONAL
Enrollment
8
Participants
Timeline
Start Date
March 31, 2007
Primary Completion Date
May 31, 2009
Study Completion Date
May 31, 2009
Conditions
Pompe Disease (Late-Onset)Glycogen Storage Disease Type II (GSD II)Glycogenesis 2 Acid Maltase Deficiency
Trial Locations (1)
Unknown
Pitie-Salpetriere Hospital, Paris
All Listed Sponsors
lead
Genzyme, a Sanofi Company
INDUSTRY
NCT00731081 - Study About the Evolution of Severe Late Onset Pompe Disease Patient With Pulmonary Dysfunction and Receiving Myozyme® | Biotech Hunter | Biotech Hunter